Related Experiment Videos
Should we genetically test everyone for haemochromatosis?
1Murdoch Institute, Royal Children's Hospital, Melbourne, Australia.
Journal of Medical Ethics
|May 5, 1999
Summary
Population-wide DNA screening for hemochromatosis is recommended. Early DNA testing for hemochromatosis can prevent and treat the disease, especially in at-risk ethnic communities.
Area of Science:
- Medical Genetics
- Public Health
- Bioethics
Background:
- DNA-based diagnostic tests are increasingly available, prompting discussions on population-wide screening.
- Genetic testing raises concerns regarding potential discrimination, identification of untreatable conditions, and ethical dilemmas in prenatal diagnosis.
Purpose of the Study:
- To identify and discuss key issues surrounding DNA-based population screening for hemochromatosis.
- To argue for the support of population-based genetic screening for hemochromatosis, provided ethical and clinical concerns are addressed.
Main Methods:
- Literature review and ethical analysis of population-based genetic screening.
- Case study focusing on hemochromatosis as a model disorder for presymptomatic DNA testing.
Main Results:
- Hemochromatosis is a treatable and preventable disease when identified presymptomatically through DNA testing.
- Population-based genetic screening for hemochromatosis presents an ethical and clinical imperative.
Conclusions:
- Population-based genetic screening for hemochromatosis should be supported when contentious issues are resolved.
- Presymptomatic DNA testing for hemochromatosis is crucial for relevant ethnic communities within resource-limited health systems.